Bayhorse Silver Expands Bayhorse Breccia Zone: Anomalous Copper-Zinc Assays from 90m to 1,050ft Depth and Preliminary IP Results for the First 115m of the Breccia Zone

Bayhorse Silver Discovers Significant Copper, Zinc, and Gold Values in Drill Results at the Bayhorse Silver Mine, Vancouver, BC Vancouver, BC – Bayhorse Silver Inc. (TSXV: BHS) (OTCQB: BHSIF) (FSE: 7KXN) (the “Company” or “Bayhorse”) is pleased to announce that assay results have been received for the first 115 meters (380 ft) of the silicified…

Read More

Exploring the Emotional Rollercoaster: Ethereum Dips Below $2,000 – A Heartfelt Analysis of Crypto’s Volatility

The Dramatic $165 Million Ethereum Liquidation Event: A Deep Dive In the dynamic and ever-evolving world of cryptocurrency trading, the past 12 hours have witnessed a significant event that has left many investors and traders reeling. A massive wave of liquidations, totaling an astounding $165 million in long Ethereum (ETH) positions, has swept through the…

Read More

Embarking on a Global Journey: Huawei and Industry Partners Prepare for the Highly Anticipated Redcap Commercial Release

At the Global Mobile Broadband Forum (MBBF) 2023, Huawei and its industry partners released the latest commercial RedCap achievements A Key Milestone for RedCap Industry During the Global Mobile Broadband Forum (MBBF) 2023, Huawei and its industry partners made a significant announcement regarding the latest commercial RedCap achievements. This announcement showcased that RedCap has officially…

Read More

Crypto Fundamental Analysis for Beginners: A Charming and Engaging Guide

Crypto Fundamental Analysis for Beginners Introduction Charmingly eccentric, full of personality, and designed for maximum reader engagement, the realm of cryptocurrency trading is a fascinating world. Analysis plays a pivotal role in guiding crypto traders in their decision-making processes. There are three main types of analysis that are commonly used by traders: fundamental analysis, technical…

Read More

Unlocking the Potential of AXS-12: A Promising Treatment for Narcolepsy – A Closer Look at Axsome’s Latest Positive Data Release

Axsome’s AXS-12 Phase 3 Study Shows Promising Results for Narcolepsy Patients Introduction Axsome Therapeutics recently announced that its drug AXS-12 has met its primary endpoint in a Phase 3 study, showing significant reduction in cataplexy attacks in narcolepsy patients. This achievement positions AXS-12 for a potential New Drug Application (NDA) submission in the near future….

Read More